(19)
(11) EP 2 560 676 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
12.10.2016 Bulletin 2016/41

(45) Mention of the grant of the patent:
10.08.2016 Bulletin 2016/32

(21) Application number: 11772360.1

(22) Date of filing: 22.04.2011
(51) International Patent Classification (IPC): 
A01N 43/42(2006.01)
A61P 25/18(2006.01)
A61P 25/14(2006.01)
 A61K 31/44(2006.01)
A61P 25/24(2006.01)
A61P 25/20(2006.01)
(86) International application number:
PCT/US2011/000719
(87) International publication number:
WO 2011/133224 (27.10.2011 Gazette 2011/43)

(54)

ORGANIC COMPOUNDS

ORGANISCHE VERBINDUNGEN

COMPOSÉS ORGANIQUES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 22.04.2010 US 327049 P
26.07.2010 US 367609 P

(43) Date of publication of application:
27.02.2013 Bulletin 2013/09

(73) Proprietor: Intra-Cellular Therapies, Inc.
New York, NY 10016 (US)

(72) Inventors:
  • MATES, Sharon
    NY 10032 (US)
  • LI, Peng
    NY 10032 (US)
  • TOMESCH, John, Charles
    NY 10032 (US)
  • DAVIS, Robert
    NY 10032 (US)
  • WENNOGLE, Lawrence, P.
    NY 10032 (US)
  • ZHANG, Qiang
    NY 10032 (US)

(74) Representative: Chapman, Paul Gilmour et al
Marks & Clerk LLP Atholl Exchange 6 Canning Street
Edinburgh EH3 8EG
Edinburgh EH3 8EG (GB)


(56) References cited: : 
WO-A1-00/77002
US-A1- 2004 180 875
US-A1- 2008 280 941
 WO-A1-2009/145900
US-A1- 2004 220 178
US-B1- 6 552 017
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).